fingolimod hydrochloride has been researched along with Renal Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JF; Liu, BC; Liu, H; Ma, KL; Ni, HF; Pan, MM; Tang, RN; Zhang, JD; Zhang, MH | 1 |
| David, OJ; Emotte, C; Kobalava, Z; Meiser, K; Moiseev, V; Picard, F; Pryce, M; Schmouder, R | 1 |
1 trial(s) available for fingolimod hydrochloride and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of fingolimod and metabolites in subjects with severe renal impairment: An open-label, single-dose, parallel-group study.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Male; Middle Aged; Renal Insufficiency | 2015 |
1 other study(ies) available for fingolimod hydrochloride and Renal Insufficiency
| Article | Year |
|---|---|
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
Topics: Animals; Cell Movement; Chemokine CCL2; Disease Models, Animal; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Interleukin-6; Kidney Tubules; Lymphocytes; Male; Nephrectomy; Nephritis, Interstitial; Propylene Glycols; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Sphingosine; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |